For 60 years, sequence and structure has been the primary lens to understand protein function. It’s now time to look beyond and leverage the orchestration of protein function within cells.
Cedilla Therapeutics is bringing a new dimension to precision oncology. We have discovered new ways to selectively inhibit oncogenic drivers with small molecules that conditionally modulate proteins in their functional state. Our conditional inhibitors are unlocking critical and elusive cancer targets including TEAD and CDK2.
We are a driven and patient-focused team.
Company Details
- Employees
- 6
- Founded
- -
- Address
- 245 First Street,
- in****@****atx.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- cedillatx.com
- Keywords
- Biotechnology, Protein, Life Sciences, Third Rock Ventures, Oncology, Science, Medicine, Team.
- HQ
- Cambridge, Massachusetts
Cedilla Therapeutics Questions
Cedilla Therapeutics's website is cedillatx.com
Cedilla Therapeutics's LinkedIn profile is https://www.linkedin.com/company/cedillatherapeutics
Cedilla Therapeutics has
6 employees.
View email and phone details for 6
employees at Cedilla Therapeutics.
Cedilla Therapeutics's industry is
Biotechnology Research
Cedilla Therapeutics's top competitors are
Casma Therapeutics,
Beam Therapeutics,
Nimbus Therapeutics,
Moma Therapeutics,
Tango Therapeutics,
Tessera Therapeutics,
Relay Therapeutics,
Magnet Biomedicine,
Celsius Therapeutics,
Agios Pharmaceuticals.
Cedilla Therapeutics's support email address is info@cedillatx.com
Cedilla Therapeutics's categories are Biotechnology Research
Cedilla Therapeutics's founding year is 2018
